Hormone Therapy's hidden effects: new study eyes metabolism and heart risks

NCT ID NCT04838249

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study observes 80 transgender individuals starting cross-sex hormone therapy (testosterone or estrogen) to see how it changes eating behavior, metabolism, weight, and heart health. Participants are followed over time with no extra treatments or procedures. The goal is to understand how sex hormones influence the body, which could help prevent obesity, diabetes, and heart disease in this group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
testosterone and estradiol/antiandrogens
What this could lead to
If successful, this study could reveal how sex hormones influence weight, metabolism, and heart disease risk, potentially improving long-term care for transgender individuals.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not apply to all populations, and the small size (80 participants) limits generalizability.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADIPOSITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Helmholtz Institute for Metabolic, Obesity and Vascular Research

    RECRUITING

    Leipzig, Saxony, 04103, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.